Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited (RDY) Stock Overview

Explore Dr. Reddy's Laboratories Limited’s financial performance, market position, analyst ratings, and future outlook.

RDY●NYSE
HealthcareDrug Manufacturers - Specialty & Generic
$12.40
$0.04(0.36%)
U.S. Market is Open · 14:50

Dr. Reddy's Laboratories Limited (RDY)

Meyka AI Score

Z

Key Financials

Market Cap10.3B
P/E Ratio29.66
EPS (TTM)$0.61
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$13.00
3 Months$10.34
1 Year Target$13.30

RDY Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Dr. Reddy's Laboratories Limited (NYSE: RDY) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Dr. Reddy's Laboratories Limited's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RDY on the NYSE shows an RSI of 47.93, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $13.30 for the NYSE listing.

Key metrics behind Dr. Reddy's Laboratories Limited's NYSE-traded stock include a P/E ratio of 29.66 and a market capitalization of 10.3B. Combined with our AI analysis, these give both institutional and retail investors a clear view of RDY on the NYSE.

Price Performance (NYSE: RDY)

1-Day Change
-0.52%
5-Day Change
1.60%
1-Month Change
-6.10%
3-Month Change
-0.60%
6-Month Change
-13.45%
Year-to-Date (YTD) Change
-11.79%
1-Year Change
-10.96%
3-Year Change
-12.60%
5-Year Change
-2.02%
All-Time (Max) Change
1126.24%

Contact Information

https://www.drreddys.com
91 40 4900 2900
8-2-337, Road No. 3, Hyderabad, TS, 500034

Company Facts

275,270 Employees
IPO DateApr 11, 2001
CountryIN
Actively Trading

Frequently Asked Questions